InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Bisker-Leib Vered, 首席运营官. Officer active across 1 company, notably Compass Therapeutics, Inc.. Aggregated, 7 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €87k. Activity tracked since 16 November 2021. The latest transaction was disclosed on 8 February 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Bisker-Leib Vered
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
49,198 股@ US$1.452.0% 占其流量Common StockSEC:0001171843-24-000715:0
1,753,125 股@ US$1.9392.7% 占其流量Common StockSEC:0001171843-24-000179:0
64,415 股@ US$1.502.7% 占其流量Common StockSEC:0001171843-23-007223:0
400,000 股0Common StockSEC:0001171843-23-000846:0
14,929 股@ US$4.191.8% 占其流量Common StockSEC:0001171843-22-007662:0
6,226 股@ US$4.400.8% 占其流量Common StockSEC:0001171843-22-007635:0
600,000 股0Common StockSEC:0000899243-21-045309:0
7 条申报中的 7 条
About Bisker-Leib Vered
Bisker-Leib Vered is Chief Operating Officer and is linked to Compass Therapeutics, Inc., where she holds the role of CHIEF EXECUTIVE OFFICER. She has 7 filings in total, and across the 7 sampled filings between 2021-11-18 and 2024-02-09, sales total 87491 EUR and no purchases are shown; the most frequent transaction nature is Attribution.
